Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how PLx Pharma Inc. turns revenue into operating income and net income.
| Metric | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $8.21M | $30,430 | $565,464 | $753,108 | $778,657 | $0 | $0 | $0 | $0 | $0 |
| Revenue Growth? | +26873.4% | -94.6% | -24.9% | -3.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $4.80M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit? | $3.40M | $30,430 | $565,464 | $753,108 | $778,657 | $0 | $0 | $0 | $0 | $0 |
| Gross Margin? | +41.5% | +100.0% | +100.0% | +100.0% | +100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $44.19M | $13.49M | $14.77M | $11.71M | $14.33M | $21.37M | $18.76M | $13.58M | $4.01M | $1.84M |
| Operating Income? | -$40.79M | -$13.46M | -$14.20M | -$10.96M | -$15.85M | -$21.37M | -$18.76M | -$13.58M | -$4.01M | -$1.84M |
| EBITDA? | -$35.24M | -$14.49M | -$13.80M | $2.24M | -$15.10M | -$21.32M | -$18.74M | -$13.58M | -$4.01M | -$1.84M |
| Income Before Tax | -$46.13M | -$15.21M | -$20.50M | $896,480 | -$16.27M | -$21.32M | -$18.74M | -$13.58M | -$4.01M | -$1.84M |
| Income Tax Expense | $5.33M | -$107,664 | $836,726 | $0 | -$920,000 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$51.46M | -$15.10M | -$21.34M | $896,480 | -$15.35M | -$21.32M | -$18.74M | -$13.58M | -$4.01M | -$1.84M |
| EPS? | $-2.18 | $-1.55 | $-2.39 | $0.10 | $-2.19 | $-16.45 | $-15.90 | $-13.84 | $-6.94 | $-3.64 |
| Diluted EPS? | $-2.18 | $-1.55 | $-2.39 | $0.10 | $-2.19 | $-16.45 | $-15.90 | $-13.84 | $-6.94 | $-3.64 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality